{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:48:07Z","timestamp":1789534087909,"version":"build-2803163510"},"reference-count":146,"publisher":"Bentham Science Publishers Ltd.","issue":"24","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Gouty arthritis is a complex form of inflammatory arthritis, triggered\nby the sedimentation of monosodium urate crystals in periarticular tissues, synovial\njoints, and other sites in the body. Curcumin is a natural polyphenol compound, isolated\nfrom the rhizome of the plant Curcuma longa, possessing countless physiological\nfeatures, including antioxidant, anti-inflammatory, and anti-rheumatic qualities.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aimed to discuss the beneficial impacts of curcumin and its mechanism\nin treating gout disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Ten English and Persian databases were used to conduct a thorough literature\nsearch. Studies examining the anti-gouty arthritis effects of curcumin and meeting the inclusion\ncriteria were included.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>According to the studies, curcumin has shown xanthine oxidase and urate transporter-\n1 inhibitory properties, uric acid inhibitory characteristics, and antioxidant and anti-\ninflammatory effects. However, some articles found no prominent reduction in uric\nacid levels.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In this review, we emphasized the potency of curcumin and its compounds\nagainst gouty arthritis. Despite the potency, we suggest an additional well-designed evaluation\nof curcumin, before its therapeutic effectiveness is completely approved as an antigouty\narthritis agent.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230721154653","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T04:37:37Z","timestamp":1690259857000},"page":"3715-3732","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-gout and Urate-lowering Potentials of Curcumin: A Review from\nBench to Beside"],"prefix":"10.2174","volume":"31","author":[{"given":"Amir Masoud","family":"Jafari-Nozad","sequence":"first","affiliation":[{"name":"Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirsajad","family":"Jafari","sequence":"additional","affiliation":[{"name":"Department of Basic\nSciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Yousefi","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine,\nShahrekord Branch, Islamic Azad University, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Bakhshi","sequence":"additional","affiliation":[{"name":"Vector-borne Diseases Research Center,\nNorth Khorasan University of Medical Sciences, Bojnurd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Farkhondeh","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Pharmacology,\nSchool of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Samarghandian","sequence":"additional","affiliation":[{"name":"Healthy Ageing Research\nCentre, Neyshabur University of Medical Sciences, Neyshabur 9318614139, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"110590","DOI":"10.1016\/j.biopha.2020.110590","volume":"130","year":"2020","unstructured":"Talebi, M.; Talebi, M.; Farkhondeh, T.; Samarghandian, S. Molecular mechanism-based therapeutic properties of honey. Biomed Pharmacother  2020,130,110590","journal-title":"Biomed Pharmacother"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1189\/jlb.3MA0915-418R","volume":"99","author":"Galv\u00e3o I.","year":"2016","unstructured":"Galv\u00e3o I.; Dias A.C.F.; Tavares L.D.; Rodrigues I.P.S.; Queiroz-Junior C.M.; Costa V.V.; Reis A.C.; Ribeiro Oliveira R.D.; Louzada-Junior P.; Souza D.G.; Leng L.; Bucala R.; Sousa L.P.; Bozza M.T.; Teixeira M.M.; Amaral F.A.; Macrophage migration inhibitory factor drives neutrophil accumulation by facilitating IL-1\u03b2 production in a murine model of acute gout. J Leukoc Biol  2016,99(6),1035-1043","journal-title":"J Leukoc Biol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/art.27338","volume":"62","author":"Bhole V.","year":"2010","unstructured":"Bhole V.; de Vera M.; Rahman M.M.; Krishnan E.; Choi H.; Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. Arthritis Rheum  2010,62(4),1069-1076","journal-title":"Arthritis Rheum"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.metop.2021.100100","volume":"11","author":"Patil T.","year":"2021","unstructured":"Patil T.; Soni A.; Acharya S.; A brief review on in vivo models for gouty arthritis. Metabolism Open  2021,11,100100","journal-title":"Metabolism Open"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.molmed.2017.06.005.","volume":"23","author":"Desai J.","year":"2017","unstructured":"Desai J.; Steiger S.; Molecular pathophysiology of gout. Trends Mol Med  2017,23(8),756-768","journal-title":"Trends Mol Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"Dehlin M.","year":"2020","unstructured":"Dehlin M.; Jacobsson L.; Roddy E.; Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol  2020,16(7),380-390","journal-title":"Nat Rev Rheumatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.2337\/db12-1814","volume":"62","author":"Johnson R.J.","year":"2013","unstructured":"Johnson R.J.; Nakagawa T.; Sanchez-Lozada L.G.; Shafiu M.; Sundaram S.; Le M.; Ishimoto T.; Sautin Y.Y.; Lanaspa M.A.; Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes  2013,62(10),3307-3315","journal-title":"Diabetes"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep39551","volume":"6","author":"Bugyei-Twum A.","year":"2016","unstructured":"Bugyei-Twum A.; Abadeh A.; Thai K.; Zhang Y.; Mitchell M.; Kabir G.; Connelly K.A.; Suppression of NLRP3 inflammasome activation ameliorates chronic kidney disease-induced cardiac fibrosis and diastolic dysfunction. Sci Rep  2016,6(1),1-11","journal-title":"Sci Rep"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.intimp.2016.12.031.","volume":"44","author":"Dinesh P.","year":"2017","unstructured":"Dinesh P.; Rasool M.; Berberine, an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats. Int Immunopharmacol  2017,44,26-37","journal-title":"Int Immunopharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/art.24185.","volume":"60","author":"Martin W.J.","year":"2009","unstructured":"Martin W.J.; Walton M.; Harper J.J.A.; Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum  2009,60(1),281-9","journal-title":"Arthritis Rheum"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"Martinon F.","year":"2006","unstructured":"Martinon F.; P\u00e9trilli V.; Mayor A.; Tardivel A.; Tschopp J.J.N.; Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature  2006,440(7081),237-41","journal-title":"Nature"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/RHU.0b013e31827d8790","volume":"19","author":"Cronstein B.N.","year":"2013","unstructured":"Cronstein B.N.; Sunkureddi P.; Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. J Clin Rheumatol  2013,19(1),19-29","journal-title":"J Clin Rheumatol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1358\/dof.2010.35.2.1426640","volume":"35","author":"Shehzad A.","year":"2010","unstructured":"Shehzad A.; Lee Y.J.D.F.; Curcumin: Multiple molecular targets mediate multiple pharmacological actions- A review. Drugs Future  2010,35(2),113","journal-title":"Drugs Future"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.2174\/0929867329666220817125800","volume":"30","author":"Jafari-Nozad A.M.","year":"2022","unstructured":"Jafari-Nozad A.M.; Jafari A.; Aschner M.; Farkhondeh T.; Samarghandian S.; Curcumin combats against organophosphate pesticides toxicity: A review of the current evidence and molecular pathways. Curr Med Chem  2022,30(20),2312-2339","journal-title":"Curr Med Chem"},{"key":"ref=15","first-page":"194","volume":"5","author":"Aldebasi Y.H.","year":"2013","unstructured":"Aldebasi Y.H.; Aly S.M.; Rahmani A.; Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways. Int J Physiol Pathophysiol Pharmacol  2013,5(4),194-202","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/abr.abr_147_16","volume":"7","author":"Rahmani A.H.","year":"2018","unstructured":"Rahmani A.H.; Alsahli M.A.; Aly S.M.; Khan M.A.; Aldebasi Y.H.; Role of curcumin in disease prevention and treatment. Adv Biomed Res  2018,7,38","journal-title":"Adv Biomed Res"},{"key":"ref=17","first-page":"126","volume":"13","author":"Sankhwar R.","year":"2021","unstructured":"Sankhwar R.; Yadav S.; Kumar A.; Kr. Gupta R.; Application of nano-curcumin as a natural antimicrobial agent against gram-positive pathogens. J Appl Nat Sci  2021,13(1),126","journal-title":"J Appl Nat Sci"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Samarghandian, S.; Borji, A.; Hidar Tabasi, S. Effects of Cichorium intybus linn on blood glucose, lipid constituents and selected oxidative stress parameters in streptozotocin-induced diabetic rats. Cardiovasc. Haematological Disord. Drug Targets. (Formerly Current Drug Targets-Cardiovasc. Hematol. Disord.), 2013, 13(3), 231-236.","DOI":"10.2174\/1871529X13666131129103139"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"S706","DOI":"10.1016\/S2221-1691(12)60300-1","volume":"2","author":"Mathews V.","year":"2012","unstructured":"Mathews V.; Binu P.; Paul M.S.; Abhilash M.; Manju A.; Hepatoprotective efficacy of curcumin against arsenic trioxide toxicity. Asian Pac J Trop Biomed  2012,2(2),S706-S711","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/jcp.26848","volume":"234","author":"Mokhtari-Zaer A.","year":"2019","unstructured":"Mokhtari-Zaer A.; Marefati N.; Atkin S.L.; Butler A.E.; Sahebkar A.; The protective role of curcumin in myocardial ischemia\u2013reperfusion injury. J Cell Physiol  2019,234(1),214-222","journal-title":"J Cell Physiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.cell.2007.08.024","volume":"130","author":"Singh S.","year":"2007","unstructured":"Singh S.; From exotic spice to modern drug? Cell  2007,130(5),765-768","journal-title":"Cell"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.2174\/0929867330666230112092802","volume":"30","author":"Jafari-Nozad A.M.","year":"2023","unstructured":"Jafari-Nozad A.M.; Jafari A.; Zangooie A.; Behdadfard M.; Zangouei A.S.; Aschner M.; Curcumin combats against gastrointestinal cancer: A review of current knowledge regarding epigenetics mechanisms with a focus on DNA methylation. Curr Med Chem  2023,30(38),4374-4388","journal-title":"Curr Med Chem"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1017\/S0007114509993667","volume":"103","author":"Epstein J.","year":"2010","unstructured":"Epstein J.; Sanderson I.R.; Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies. Br J Nutr  2010,103(11),1545-57","journal-title":"Br J Nutr"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Shaterzadeh-Yazdi, H.; Noorbakhsh, M.F.; Hayati, F.; Samarghandian, S.; Farkhondeh, T. Immunomodulatory and anti-inflammatory effects of thymoquinone. Cardiovasc. Haematological. Disord. Drug Targets (Formerly Current Drug Targets-Cardiovascular and Hematological Disorders). 2018, 18(1), 52-60.","DOI":"10.2174\/1871529X18666180212114816"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1002\/jcp.27442.","volume":"234","author":"Farhood B.","year":"2019","unstructured":"Farhood B.; Mortezaee K.; Goradel N.H.; Khanlarkhani N.; Salehi E.; Nashtaei M.S.;  Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy. J Cell Physiol  2019,234(5),5728-5740","journal-title":"J Cell Physiol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/JIR.S205390","volume":"12","author":"Gupte P.A.","year":"2019","unstructured":"Gupte P.A.; Giramkar S.A.; Harke S.M.; Kulkarni S.K.; Deshmukh A.P.; Hingorani L.L.; Mahajan M.P.; Bhalerao S.S.; Evaluation of the efficacy and safety of Capsule Longvida Optimized curcumin (solid lipid curcumin particles) in knee osteoarthritis: A pilot clinical study. J Inflamm Res  2019,12,145-152","journal-title":"J Inflamm Res"},{"key":"ref=27","doi-asserted-by":"publisher","unstructured":"Samarghandian, S.; Samini, F.; Azimi-Nezhad, M.; Farkhondeh, T. Anti-oxidative effects of safranal on immobilization-induced oxidative damage in rat brain. Neurosci Lett. 2017; 659:26-32.","DOI":"10.1016\/j.neulet.2017.08.065"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/ar3552","volume":"14","author":"Gaffo A.L.","year":"2012","unstructured":"Gaffo A.L.; Jacobs D.R.; Lewis C.E.; Mikuls T.R.; Saag K.G.; Association between being African-American, serum urate levels and the risk of developing hyperuricemia: Findings from the Coronary Artery Risk Development in Young Adults cohort. Arthritis Res Ther  2012,14(1),R4","journal-title":"Arthritis Res Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.3949\/ccjm.75.Suppl_5.S13","volume":"75","author":"Edwards N.L.","year":"2008","unstructured":"Edwards N.L.; The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med  2008,75(Suppl. 5),S13-S16","journal-title":"Cleve Clin J Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1080\/15257770.2011.596496","volume":"30","author":"Yamanaka H.","year":"2011","unstructured":"Yamanaka H.; Japanese guideline for the management of hyperuricemia and gout: Second edition. Nucleosides Nucleotides Nucleic Acids  2011,30(12),1018-1029","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar1906","volume":"8","author":"Nuki G.","year":"2006","unstructured":"Nuki G.; Simkin P.A.; A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther  2006,8(Suppl 1),S1","journal-title":"Arthritis Res Ther"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1021\/np8007123","volume":"72","author":"Pauff J.M.","year":"2009","unstructured":"Pauff J.M.; Hille R.; Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin. J Nat Prod  2009,72(4),725-731","journal-title":"J Nat Prod"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/19390211.2020.1757798","volume":"18","author":"Bupparenoo P.","year":"2021","unstructured":"Bupparenoo P.; Pakchotanon R.; Narongroeknawin P.; Asavatanabodee P.; Chaiamnuay S.; Effect of curcumin on serum urate in asymptomatic hyperuricemia: A randomized placebo-controlled trial. J Diet Suppl  2021,18(3),248-260","journal-title":"J Diet Suppl"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/carcin\/15.8.1717","volume":"15","author":"Lin J.K.","year":"1994","unstructured":"Lin J.K.; Shih C.A.; Inhibitory effect of curcumin on xanthine dehydrogenase\/oxidase induced by phorbol-12-myristate-13-acetate in NJH3T3 cells. Carcinogenesis  1994,15(8),1717-1721","journal-title":"Carcinogenesis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"5990","DOI":"10.1016\/j.bmcl.2009.09.076","volume":"19","author":"Shen L.","year":"2009","unstructured":"Shen L.; Ji H.F.; Insights into the inhibition of xanthine oxidase by curcumin. Bioorg Med Chem Lett  2009,19(21),5990-5993","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bmc.2016.10.022","volume":"25","author":"Ao G.Z.","year":"2017","unstructured":"Ao G.Z.; Zhou M.Z.; Li Y.Y.; Li S.N.; Wang H.N.; Wan Q.W.; Li H.Q.; Hu Q.H.; Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents. Bioorg Med Chem  2017,25(1),166-174","journal-title":"Bioorg Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0378-8741(00)00305-6","volume":"73","author":"Kong L.D.","year":"2000","unstructured":"Kong L.D.; Cai Y.; Huang W.W.; Cheng C.H.K.; Tan R.X.; Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol  2000,73(1-2),199-207","journal-title":"J Ethnopharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1021\/np970237h","volume":"61","author":"Cos P.","year":"1998","unstructured":"Cos P.; Ying L.; Calomme M.; Hu J.P.; Cimanga K.; Van Poel B.; Pieters L.; Vlietinck A.J.; Berghe D.V.; Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod  1998,61(1),71-76","journal-title":"J Nat Prod"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0006-291X(02)00442-4","volume":"294","author":"Lin C.M.","year":"2002","unstructured":"Lin C.M.; Chen C.S.; Chen C.T.; Liang Y.C.; Lin J.K.; Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem Biophys Res Commun  2002,294(1),167-172","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/14786410601129648","volume":"21","author":"Wang F.","year":"2007","unstructured":"Wang F.; Yang L.; Huang K.; Li X.; Hao X.; St\u00f6ckigt J.; Zhao Y.; Preparation of ferulic acid derivatives and evaluation of their xanthine oxidase inhibition activity. Nat Prod Res  2007,21(3),196-202","journal-title":"Nat Prod Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jnutbio.2013.09.013","volume":"25","author":"Chuengsamarn S.","year":"2014","unstructured":"Chuengsamarn S.; Rattanamongkolgul S.; Phonrat B.; Tungtrongchitr R.; Jirawatnotai S.; Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: A randomized controlled trial. J Nutr Biochem  2014,25(2),144-150","journal-title":"J Nutr Biochem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/FJC.0000000000000406","volume":"68","author":"Panahi Y.","year":"2016","unstructured":"Panahi Y.; Kianpour P.; Mohtashami R.; Jafari R.; Simental-Mend\u00eda L.E.; Sahebkar A.; Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: A randomized controlled trial. J Cardiovasc Pharmacol  2016,68(3),223-229","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2174\/1389450120666181122100511","volume":"20","author":"Malik N.","year":"2019","unstructured":"Malik N.; Dhiman P.; Khatkar A.; In silico design and synthesis of targeted curcumin derivatives as xanthine oxidase inhibitors. Curr Drug Targets  2019,20(5),593-603","journal-title":"Curr Drug Targets"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.fitote.2011.12.028","volume":"83","author":"Peng F.","year":"2012","unstructured":"Peng F.; Tao Q.; Wu X.; Dou H.; Spencer S.; Mang C.; Xu L.; Sun L.; Zhao Y.; Li H.; Zeng S.; Liu G.; Hao X.; Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger. Fitoterapia  2012,83(3),568-585","journal-title":"Fitoterapia"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1021\/jm1015022","volume":"54","author":"Wempe M.F.","year":"2011","unstructured":"Wempe M.F.; Jutabha P.; Quade B.; Iwen T.J.; Frick M.M.; Ross I.R.; Rice P.J.; Anzai N.; Endou H.; Developing potent human uric acid transporter 1 (hURAT1) inhibitors. J Med Chem  2011,54(8),2701-2713","journal-title":"J Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/sj.bjp.0702803","volume":"128","author":"Kang B.Y.","year":"1999","unstructured":"Kang B.Y.; Song Y.J.; Kim K.M.; Choe Y.K.; Hwang S.Y.; Kim T.S.; Curcumin inhibits Th1 cytokine profile in CD4  T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol  1999,128(2),380-384","journal-title":"Br J Pharmacol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00011-009-0063-1","volume":"58","author":"Mathy-Hartert M.","year":"2009","unstructured":"Mathy-Hartert M.; Jacquemond-Collet I.; Priem F.; Sanchez C.; Lambert C.; Henrotin Y.; Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res  2009,58(12),899-908","journal-title":"Inflamm Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0167-4943(01)00194-7","volume":"34","author":"Miquel J.","year":"2002","unstructured":"Miquel J.; Bernd A.; Sempere J.M.; D\u00edaz-Alperi J.; Ram\u00edrez A.; The curcuma antioxidants: Pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr  2002,34(1),37-46","journal-title":"Arch Gerontol Geriatr"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e14280","DOI":"10.1111\/ijcp.14280","volume":"75","author":"Pourhabibi-Zarandi F.","year":"2021","unstructured":"Pourhabibi-Zarandi F.; Shojaei-Zarghani S.; Rafraf M.; Curcumin and rheumatoid arthritis: A systematic review of literature. Int J Clin Pract  2021,75(10),e14280","journal-title":"Int J Clin Pract"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/107555303321223035","volume":"9","author":"Chainani-Wu N.","year":"2003","unstructured":"Chainani-Wu N.; Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J Altern Complement Med  2003,9(1),161-168","journal-title":"J Altern Complement Med"},{"key":"ref=51","doi-asserted-by":"crossref","unstructured":"Samarghandian, S.; Shoshtari, M.E.; Sargolzaei, J.; Hossinimoghadam, H.; Farahzad, J.A. Anti-tumor activity of safranal against neuroblastoma cells. Pharmacogn. Mag., 2014, 10(Suppl 2), S419.","DOI":"10.4103\/0973-1296.133296"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"107375","DOI":"10.1016\/j.intimp.2021.107375","volume":"93","author":"Gu Y.","year":"2021","unstructured":"Gu Y.; Zhu Y.; Deng G.; Liu S.; Sun Y.; Lv W.; Curcumin analogue AI-44 alleviates MSU-induced gouty arthritis in mice via inhibiting cathepsin B-mediated NLRP3 inflammasome activation. Int Immunopharmacol  2021,93,107375","journal-title":"Int Immunopharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"105886","DOI":"10.1016\/j.intimp.2019.105886","volume":"76","author":"Liu X.","year":"2019","unstructured":"Liu X.; Jin X.; Yu D.; Liu G.; Suppression of NLRP3 and NF-\u03baB signaling pathways by \u03b1-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice. Int Immunopharmacol  2019,76,105886","journal-title":"Int Immunopharmacol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/art.41245","volume":"72","author":"Yang G.","year":"2020","unstructured":"Yang G.; Lee H.E.; Moon S.J.; Ko K.M.; Koh J.H.; Seok J.K.; Min J.K.; Heo T.H.; Kang H.C.; Cho Y.Y.; Lee H.S.; Fitzgerald K.A.; Lee J.Y.; Direct binding to NLRP3 pyrin domain as a novel strategy to prevent NLRP3-driven inflammation and gouty arthritis. Arthritis Rheumatol  2020,72(7),1192-1202","journal-title":"Arthritis Rheumatol"},{"key":"ref=55","first-page":"63","volume":"33","author":"Yuan X.","year":"2019","unstructured":"Yuan X.; Fan Y.S.; Xu L.; Xie G.Q.; Feng X.H.; Qian K.; Jia-Wei-Si-Miao-Wan alleviates acute gouty arthritis by targeting NLRP3 inflammasome. J Biol Regul Homeost Agents  2019,33(1),63-71","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref=56","doi-asserted-by":"publisher","unstructured":"Samarghandian, S.; Azimi-Nezhad, M.; Samini, F.; Preventive effect of safranal against oxidative damage in aged male rat brain. Experimental Animals. 2015; 64(1):65-71.","DOI":"10.1538\/expanim.14-0027"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.canlet.2019.02.035","volume":"449","author":"Mijanovi\u0107 O.","year":"2019","unstructured":"Mijanovi\u0107 O.; Brankovi\u0107 A.; Panin A.N.; Savchuk S.; Timashev P.; Ulasov I.; Lesniak M.S.; Cathepsin B: A sellsword of cancer progression. Cancer Lett  2019,449,207-214","journal-title":"Cancer Lett"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"80262","DOI":"10.18632\/oncotarget.12918","volume":"7","author":"Peng S.","year":"2016","unstructured":"Peng S.; Gao J.; Liu W.; Jiang C.; Yang X.; Sun Y.; Guo W.; Xu Q.; Andrographolide ameliorates OVA-induced lung injury in mice by suppressing ROS-mediated NF-\u03baB signaling and NLRP3 inflammasome activation. Oncotarget  2016,7(49),80262-80274","journal-title":"Oncotarget"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3389\/fimmu.2018.01427","volume":"9","author":"Amaral E.P.","year":"2018","unstructured":"Amaral E.P.; Riteau N.; Moayeri M.; Maier N.; Mayer-Barber K.D.; Pereira R.M.; Lage S.L.; Kubler A.; Bishai W.R.; D\u2019Imp\u00e9rio-Lima M.R.; Sher A.; Andrade B.B.; Lysosomal cathepsin release is required for NLRP3-inflammasome activation by Mycobacterium tuberculosis in infected macrophages. Front Immunol  2018,9,1427","journal-title":"Front Immunol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jacl.2020.07.003","volume":"14","author":"Nidorf S.M.","year":"2020","unstructured":"Nidorf S.M.; Fiolet A.; Abela G.S.; Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability. J Clin Lipidol  2020,14(5),619-630","journal-title":"J Clin Lipidol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1080\/15548627.2017.1293766","volume":"13","author":"Wang D.","year":"2017","unstructured":"Wang D.; Zhang J.; Jiang W.; Cao Z.; Zhao F.; Cai T.; Aschner M.; Luo W.; The role of NLRP3-CASP1 in inflammasome-mediated neuroinflammation and autophagy dysfunction in manganese-induced, hippocampal-dependent impairment of learning and memory ability. Autophagy  2017,13(5),914-927","journal-title":"Autophagy"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"Shao B.Z.","year":"2015","unstructured":"Shao B.Z.; Xu Z.Q.; Han B.Z.; Su D.F.; Liu C.; NLRP3 inflammasome and its inhibitors: A review. Front Pharmacol  2015,6,262","journal-title":"Front Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","unstructured":"Mirzaei, S.; Zarrabi, A.; Asnaf, S.E.; Hashemi, F.; Zabolian, A.; Hushmandi, K.; Raei, M.; Goharrizi MASB, Makvandi P, Samarghandian S, Najafi M, Ashrafizadeh M, Aref AR, Hamblin MR. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators. Life Sci.  2021; 268:119005.","DOI":"10.1016\/j.lfs.2020.119005."},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cbi.2017.10.012","volume":"278","author":"Wang S.","year":"2017","unstructured":"Wang S.; Zhao X.; Yang S.; Chen B.; Shi J.; Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway. Chem Biol Interact  2017,278,48-53","journal-title":"Chem Biol Interact"},{"key":"ref=65","doi-asserted-by":"publisher","unstructured":"Shaterzadeh-Yazdi, H.; Noorbakhsh, M.F.; Hayati, F.; Samarghandian, S.; Farkhondeh, T. Immunomodulatory and anti-inflammatory effects of thymoquinone. Cardiovasc. Hematol. Disord. Drug Targets. 2018; 18(1), 52-60.","DOI":"10.2174\/1871529X18666180212114816."},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.molimm.2018.09.004","volume":"104","author":"Gong Z.","year":"2018","unstructured":"Gong Z.; Zhao S.; Zhou J.; Yan J.; Wang L.; Du X.; Li H.; Chen Y.; Cai W.; Wu J.; Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1\u03b2 production. Mol Immunol  2018,104,11-19","journal-title":"Mol Immunol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1002\/jcb.27969","volume":"120","author":"Li X.","year":"2019","unstructured":"Li X.; Xu D.Q.; Sun D.Y.; Zhang T.; He X.; Xiao D.M.; Curcumin ameliorates monosodium urate-induced gouty arthritis through nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling. J Cell Biochem  2019,120(4),6718-6728","journal-title":"J Cell Biochem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"109195","DOI":"10.1016\/j.biopha.2019.109195","volume":"118","author":"Chen Y.","year":"2019","unstructured":"Chen Y.; Li C.; Duan S.; Yuan X.; Liang J.; Hou S.; Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Biomed Pharmacother  2019,118,109195","journal-title":"Biomed Pharmacother"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13075-019-1974-z","volume":"21","author":"Chen B.","year":"2019","unstructured":"Chen B.; Li H.; Ou G.; Ren L.; Yang X.; Zeng M.; Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of I\u03baB\u03b1 and blocking mitochondrial damage. Arthritis Res Ther  2019,21(1),193","journal-title":"Arthritis Res Ther"},{"key":"ref=70","first-page":"201806797","volume":"115","author":"Banerjee S.","year":"2018","unstructured":"Banerjee S.; Ji C.; Mayfield J.E.; Goel A.; Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2. Proc National Aca Sci  2018,115(32),201806797","journal-title":"Proc National Aca Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"191624","DOI":"10.1155\/2014\/191624","volume":"2014","author":"Fan Z.","year":"2014","unstructured":"Fan Z.; Jing H.; Yao J.; Li Y.; Hu X.; Shao H.; Shen G.; Pan J.; Luo F.; Tian X.; The protective effects of curcumin on experimental acute liver lesion induced by intestinal ischemia-reperfusion through inhibiting the pathway of NF-\u03baB in a rat model. Oxid Med Cell Longev  2014,2014,191624","journal-title":"Oxid Med Cell Longev"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1179\/2045772313Y.0000000179","volume":"38","author":"Ni H.","year":"2015","unstructured":"Ni H.; Jin W.; Zhu T.; Wang J.; Yuan B.; Jiang J.; Liang W.; Ma Z.; Curcumin modulates TLR4\/NF-\u03baB inflammatory signaling pathway following traumatic spinal cord injury in rats. J Spinal Cord Med  2015,38(2),199-206","journal-title":"J Spinal Cord Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.4049\/jimmunol.1701495","volume":"200","author":"Yin H.","year":"2018","unstructured":"Yin H.; Guo Q.; Li X.; Tang T.; Li C.; Wang H.; Sun Y.; Feng Q.; Ma C.; Gao C.; Yi F.; Peng J.; Curcumin suppresses IL-1\u03b2 secretion and prevents inflammation through inhibition of the NLRP3 inflammasome. J Immunol  2018,200(8),2835-2846","journal-title":"J Immunol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2011.01043.x","volume":"243","author":"Leemans J.C.","year":"2011","unstructured":"Leemans J.C.; Cassel S.L.; Sutterwala F.S.; Sensing damage by the NLRP3 inflammasome. Immunol Rev  2011,243(1),152-162","journal-title":"Immunol Rev"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","volume":"109","author":"Ghosh S.","year":"2002","unstructured":"Ghosh S.; Karin M.; Missing pieces in the NF-kappaB puzzle. Cell  2002,109(2),S81-S96","journal-title":"Cell"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"Hayden M.S.","year":"2004","unstructured":"Hayden M.S.; Ghosh S.; Signaling to NF-\u03baB. Genes Dev  2004,18(18),2195-2224","journal-title":"Genes Dev"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"Tak P.P.","year":"2001","unstructured":"Tak P.P.; Firestein G.S.; NF-\u03baB: A key role in inflammatory diseases. J Clin Invest  2001,107(1),7-11","journal-title":"J Clin Invest"},{"key":"ref=78","volume":"58","author":"Mohamed D.A.","year":"2008","unstructured":"Mohamed D.A.; Al-Okbi S.Y.; Evaluation of anti-gout activity of some plant food extracts. Pol J Food Nutr Sci  2008,58(3)","journal-title":"Pol J Food Nutr Sci"},{"key":"ref=79","first-page":"1950","volume":"29","author":"Urano W.","year":"2002","unstructured":"Urano W.; Yamanaka H.; Tsutani H.; Nakajima H.; Matsuda Y.; Taniguchi A.; Hara M.; Kamatani N.; The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol  2002,29(9),1950-1953","journal-title":"J Rheumatol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00011-006-0067-z","volume":"55","author":"Jackson J.K.","year":"2006","unstructured":"Jackson J.K.; Higo T.; Hunter W.L.; Burt H.M.; The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res  2006,55(4),168-175","journal-title":"Inflamm Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0378-8741(93)90005-P","volume":"38","author":"Ammon H.P.T.","year":"1993","unstructured":"Ammon H.P.T.; Safayhi H.; Mack T.; Sabieraj J.; Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol  1993,38(2-3),105-112","journal-title":"J Ethnopharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0262-1746(86)90146-0","volume":"22","author":"Flynn D.L.","year":"1986","unstructured":"Flynn D.L.; Rafferty M.F.; Boctor A.M.; Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med  1986,22(3),357-360","journal-title":"Prostaglandins Leukot Med"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/00024382-200301000-00017","volume":"19","author":"Madan B.","year":"2003","unstructured":"Madan B.; Ghosh B.; Diferuloylmethane inhibits neutrophil infiltration and improves survival of mice in high-dose endotoxin shock. Shock  2003,19(1),91-96","journal-title":"Shock"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/0006-2952(93)90476-D","volume":"46","author":"Limasset B.","year":"1993","unstructured":"Limasset B.; Le Doucen C.; Dore J.C.; Ojasoo T.; Damon M.; De Paulet A.C.; Effects of flavonoids on the release of reactive oxygen species by stimulated human neutrophils. Biochem Pharmacol  1993,46(7),1257-1271","journal-title":"Biochem Pharmacol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1573401316999200421095134","volume":"17","author":"Bisset S.","year":"2020","unstructured":"Bisset S.; Sobhi W.; Bensouici C.; Khenchouche A.; Chain-breaking\/preventive antioxidant, urate-lowering, and anti-inflammatory effects of pure curcumin. Curr Nutr Food Sci  2020,17(1),66-74","journal-title":"Curr Nutr Food Sci"},{"key":"ref=86","first-page":"352","volume":"10","author":"Umar H.I.","year":"2020","unstructured":"Umar H.I.; Ajayi A.; Josiah S.S.; Saliu T.; Danjuma J.B.; Chukwuemeka P.O.; In silico molecular docking of selected polyphenols against interleukin-17A target in gouty arthritis. Eur J Biol Res  2020,10(4),352-367","journal-title":"Eur J Biol Res"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/ncomms2880","volume":"4","author":"Liu S.","year":"2013","unstructured":"Liu S.; Song X.; Chrunyk B.A.; Shanker S.; Hoth L.R.; Marr E.S.; Crystal structures of interleukin 17A and its complex with IL-17 receptor A. Nat Commun  2013,4,1888","journal-title":"Nat Commun"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.immuni.2011.09.010","volume":"35","author":"Chang S.H.","year":"2011","unstructured":"Chang S.H.; Reynolds J.M.; Pappu B.P.; Chen G.; Martinez G.J.; Dong C.; Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity  2011,35(4),611-621","journal-title":"Immunity"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"Gaffen SLJNRI.","year":"2009","unstructured":"Gaffen SLJNRI.; Structure and signalling in the IL-17 receptor family. Nat Rev Immunol  2009,9(8),556-67","journal-title":"Nat Rev Immunol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"104351","DOI":"10.1016\/j.phrs.2019.104351","volume":"147","author":"Raucci F.","year":"2019","unstructured":"Raucci F.; Iqbal A.J.; Saviano A.; Minosi P.; Piccolo M.; Irace C.; IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation. Pharmacol Res  2019,147,104351","journal-title":"Pharmacol Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3109\/08820139.2016.1153651","volume":"45","author":"Cavalcanti N.G.","year":"2016","unstructured":"Cavalcanti N.G.; Marques C.D.L.; Lins e Lins T.U.; Pereira M.C.; Cytokine profile in gout: Inflammation driven by IL-6 and IL-18? Immunol Invest  2016,45(5),383-95","journal-title":"Immunol Invest"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.bbrc.2018.02.166","volume":"497","author":"Liu Y.","year":"2018","unstructured":"Liu Y.; Zhao Q.; Yin Y.; McNutt M.A.; Zhang T.; Cao Y.; Serum levels of IL-17 are elevated in patients with acute gouty arthritis. Biochem Biophys Res Commun  2018,497(3),897-902","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"e000284","DOI":"10.1136\/rmdopen-2016-000284.","volume":"3","author":"Miossec P.","year":"2017","unstructured":"Miossec P.; Update on interleukin-17: A role in the pathogenesis of inflammatory arthritis and implication for clinical practice. RMD Open  2017,3(1),e000284","journal-title":"RMD Open"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13238-011-1006-5.","volume":"2","author":"Zhang X.","year":"2011","unstructured":"Zhang X.; Angkasekwinai P.; Dong C.; Tang H.J.P.; Structure and function of interleukin-17 family cytokines. Protein Cell  2011,2(1),26-40","journal-title":"Protein Cell"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"8659302","DOI":"10.1155\/2019\/8659302","volume":"2019","author":"Le Goff B.","year":"2019","unstructured":"Le Goff B.; Bouvard B.; Lequerre T.; Lespessailles E.; Marotte H.; Pers Y.M.; Cortet B.; Implication of IL-17 in bone loss and structural damage in inflammatory rheumatic diseases. Mediators Inflamm  2019,2019,8659302","journal-title":"Mediators Inflamm"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3908061","DOI":"10.1155\/2017\/3908061.","volume":"2017","author":"Kuwabara T.","year":"2017","unstructured":"Kuwabara T.; Ishikawa F.; Kondo M.; The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm  2017,2017,3908061","journal-title":"Mediators Inflamm"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"e0148082","DOI":"10.1371\/journal.pone.0148082.","volume":"11","author":"Zhou Z.","year":"2016","unstructured":"Zhou Z.; Li X.; Li H.; Guo M.; Liu S.; Genetic analysis of IL-17 gene polymorphisms in gout in a male Chinese Han population. PLoS One  2016,11(2),e0148082","journal-title":"PLoS One"},{"key":"ref=98","first-page":"3782","volume":"4","author":"Ranade S.Y.","year":"2013","unstructured":"Ranade S.Y.; Gaud R.S.; Current strategies in herbal drug delivery for arthritis: An overview. Int J Pharm Sci Res  2013,4(10),3782","journal-title":"Int J Pharm Sci Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/antibiotics11030322","volume":"11","author":"Hussain Y.","year":"2022","unstructured":"Hussain Y.; Alam W.; Ullah H.; Dacrema M.; Daglia M.; Khan H.; Arciola C.R.; Antimicrobial potential of curcumin: Therapeutic potential and challenges to clinical applications. Antibiotics  2022,11(3),322","journal-title":"Antibiotics"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/pharmaceutics13122102","volume":"13","author":"Sohn S.I.","year":"2021","unstructured":"Sohn S.I.; Priya A.; Balasubramaniam B.; Muthuramalingam P.; Sivasankar C.; Selvaraj A.; Valliammai A.; Jothi R.; Pandian S.; Biomedical applications and bioavailability of curcumin-An updated overview. Pharmaceutics  2021,13(12),2102","journal-title":"Pharmaceutics"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/medicina55010010","volume":"55","author":"Mustafa Kiyani M.M.","year":"2019","unstructured":"Mustafa Kiyani M.M.; Sohail M.F.; Shahnaz G.; Rehman H.; Akhtar M.F.; Nawaz I.; Mahmood T.; Manzoor M.; Imran Bokhari S.A.; Evaluation of turmeric nanoparticles as anti-gout agent: Modernization of a traditional drug. Medicina  2019,55(1),10","journal-title":"Medicina"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1021\/nn2005574","volume":"5","author":"Walsh A.S.","year":"2011","unstructured":"Walsh A.S.; Yin H.; Erben C.M.; Wood M.J.A.; Turberfield A.J.; DNA cage delivery to mammalian cells. ACS Nano  2011,5(7),5427-5432","journal-title":"ACS Nano"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4236\/ojra.2013.32015","volume":"3","author":"Appelboom T.","year":"2013","unstructured":"Appelboom T.; MsciBiost C.M.; MsciBiost CM. Flexofytol, a purified curcumin extract, in fibromyalgia and gout: A retrospective study. Open J Rheumatol Autoimmune Dis  2013,3(2),104-107","journal-title":"Open J Rheumatol Autoimmune Dis"},{"key":"ref=104","year":"2003","unstructured":"The burden of musculoskeletal conditions at the start of the new millenium: Report of a WHO scientific group. WHO Available from:  https:\/\/apps.who.int\/iris\/handle\/10665\/427212003"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"106842","DOI":"10.1016\/j.intimp.2020.106842","volume":"87","author":"Xu Y.T.","year":"2020","unstructured":"Xu Y.T.; Leng Y.R.; Liu M.M.; Dong R.F.; Bian J.; Yuan L.L.; Zhang J.; Xia Y.Z.; Kong L.Y.; MicroRNA and long noncoding RNA involvement in gout and prospects for treatment. Int Immunopharmacol  2020,87,106842","journal-title":"Int Immunopharmacol"},{"key":"ref=106","first-page":"1921","volume":"33","author":"Wortmann R.L.","year":"2006","unstructured":"Wortmann R.L.; The management of gout: It should be crystal clear. J Rheumatol  2006,33(10),1921-1922","journal-title":"J Rheumatol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"Kelley N.","year":"2019","unstructured":"Kelley N.; Jeltema D.; Duan Y.; He Y.; The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int J Mol Sci  2019,20(13),3328","journal-title":"Int J Mol Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.12458","volume":"1319","author":"Sutterwala F.S.","year":"2014","unstructured":"Sutterwala F.S.; Haasken S.; Cassel S.L.; Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci  2014,1319(1),82-95","journal-title":"Ann N Y Acad Sci"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s10067-020-05090-8","volume":"39","author":"Wu M.","year":"2020","unstructured":"Wu M.; Tian Y.; Wang Q.; Guo C.; Gout: A disease involved with complicated immunoinflammatory responses: A narrative review. Clin Rheumatol  2020,39(10),2849-2859","journal-title":"Clin Rheumatol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","volume":"15","author":"Dinarello C.A.","year":"2019","unstructured":"Dinarello C.A.; The IL-1 family of cytokines and receptors in rheumatic diseases. Nat Rev Rheumatol  2019,15(10),612-632","journal-title":"Nat Rev Rheumatol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"Dinarello C.A.","year":"2018","unstructured":"Dinarello C.A.; Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev  2018,281(1),8-27","journal-title":"Immunol Rev"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"102617","DOI":"10.1016\/j.autrev.2020.102617","volume":"19","author":"Migliorini P.","year":"2020","unstructured":"Migliorini P.; Italiani P.; Pratesi F.; Puxeddu I.; Boraschi D.; The IL-1 family cytokines and receptors in autoimmune diseases. Autoimmun Rev  2020,19(9),102617","journal-title":"Autoimmun Rev"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3389\/fimmu.2019.01412","volume":"10","author":"Fields J.K.","year":"2019","unstructured":"Fields J.K.; G\u00fcnther S.; Sundberg E.J.; Structural basis of IL-1 family cytokine signaling. Front Immunol  2019,10,1412","journal-title":"Front Immunol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/ijms20030649","volume":"20","author":"Yasuda K.","year":"2019","unstructured":"Yasuda K.; Nakanishi K.; Tsutsui H.; Interleukin-18 in health and disease. Int J Mol Sci  2019,20(3),649","journal-title":"Int J Mol Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/imr.12616","volume":"281","author":"Kaplanski G.","year":"2018","unstructured":"Kaplanski G.; Interleukin-18: Biological properties and role in disease pathogenesis. Immunol Rev  2018,281(1),138-153","journal-title":"Immunol Rev"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fimmu.2018.00763","volume":"9","author":"Nakanishi K.","year":"2018","unstructured":"Nakanishi K.; Unique action of interleukin-18 on T cells and other immune cells. Front Immunol  2018,9,763","journal-title":"Front Immunol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1016\/j.bbrc.2018.08.139","volume":"503","author":"Choe J.Y.","year":"2018","unstructured":"Choe J.Y.; Choi C.H.; Park K.Y.; Kim S.K.; High-mobility group box 1 is responsible for monosodium urate crystal-induced inflammation in human U937 macrophages. Biochem Biophys Res Commun  2018,503(4),3248-3255","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3346\/jkms.2013.28.9.1289","volume":"28","author":"Son C.N.","year":"2013","unstructured":"Son C.N.; Bang S.Y.; Kim J.H.; Choi C.B.; Kim T.H.; Jun J.B.; Caspase-1 level in synovial fluid is high in patients with spondyloarthropathy but not in patients with gout. J Korean Med Sci  2013,28(9),1289-1292","journal-title":"J Korean Med Sci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1172\/JCI28075","volume":"116","author":"Chen C.J.","year":"2006","unstructured":"Chen C.J.; Shi Y.; Hearn A.; Fitzgerald K.; Golenbock D.; Reed G.; Akira S.; Rock K.L.; MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest  2006,116(8),2262-2271","journal-title":"J Clin Invest"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2337\/dc08-1710","volume":"32","author":"Tr\u00f8seid M.","year":"2009","unstructured":"Tr\u00f8seid M.; Seljeflot I.; Hjerkinn E.M.; Arnesen H.; Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: Synergistic effect of inflammation and hyperglycemia. Diabetes Care  2009,32(3),486-492","journal-title":"Diabetes Care"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.semarthrit.2019.11.009","volume":"50","author":"Schlesinger N.","year":"2020","unstructured":"Schlesinger N.; Brunetti L.; Beyond urate lowering: Analgesic and anti-inflammatory properties of allopurinol. Semin Arthritis Rheum  2020,50(3),444-450","journal-title":"Semin Arthritis Rheum"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.7150\/thno.48028","volume":"10","author":"Yin C.","year":"2020","unstructured":"Yin C.; Liu B.; Li Y.; Li X.; Wang J.; Chen R.; Tai Y.; Shou Q.; Wang P.; Shao X.; Liang Y.; Zhou H.; Mi W.; Fang J.; Liu B.; IL-33\/ST2 induces neutrophil-dependent reactive oxygen species production and mediates gout pain. Theranostics  2020,10(26),12189-12203","journal-title":"Theranostics"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1111\/bph.14967","volume":"177","author":"Yin C.","year":"2020","unstructured":"Yin C.; Liu B.; Wang P.; Li X.; Li Y.; Zheng X.; Tai Y.; Wang C.; Liu B.; Eucalyptol alleviates inflammation and pain responses in a mouse model of gout arthritis. Br J Pharmacol  2020,177(9),2042-2057","journal-title":"Br J Pharmacol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.freeradbiomed.2014.04.021","volume":"72","author":"Trevisan G.","year":"2014","unstructured":"Trevisan G.; Hoffmeister C.; Rossato M.F.; Oliveira S.M.; Silva M.A.; Silva C.R.; Fusi C.; Tonello R.; Minocci D.; Guerra G.P.; Materazzi S.; Nassini R.; Geppetti P.; Ferreira J.; TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger hyperalgesia and inflammation in a model of acute gout. Free Radic Biol Med  2014,72,200-209","journal-title":"Free Radic Biol Med"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1002\/art.38112","volume":"65","author":"Trevisan G.","year":"2013","unstructured":"Trevisan G.; Hoffmeister C.; Rossato M.F.; Oliveira S.M.; Silva M.A.; Ineu R.P.; Guerra G.P.; Materazzi S.; Fusi C.; Nassini R.; Geppetti P.; Ferreira J.; Transient receptor potential ankyrin 1 receptor stimulation by hydrogen peroxide is critical to trigger pain during monosodium urate-induced inflammation in rodents. Arthritis Rheum  2013,65(11),2984-2995","journal-title":"Arthritis Rheum"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"Dostert C.","year":"2008","unstructured":"Dostert C.; P\u00e9trilli V.; Van Bruggen R.; Steele C.; Mossman B.T.; Tschopp J.; Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science  2008,320(5876),674-677","journal-title":"Science"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"Zhou R.","year":"2011","unstructured":"Zhou R.; Yazdi A.S.; Menu P.; Tschopp J.; A role for mitochondria in NLRP3 inflammasome activation. Nature  2011,469(7329),221-225","journal-title":"Nature"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fimmu.2019.00070","volume":"10","author":"Alberts B.M.","year":"2019","unstructured":"Alberts B.M.; Bruce C.; Basnayake K.; Ghezzi P.; Davies K.A.; Mullen L.M.; Secretion of IL-1\u03b2 from monocytes in gout is redox independent. Front Immunol  2019,10,70","journal-title":"Front Immunol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.3390\/ijms22179221","volume":"22","author":"Yanai H.","year":"2021","unstructured":"Yanai H.; Adachi H.; Hakoshima M.; Katsuyama H.; Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci  2021,22(17),9221","journal-title":"Int J Mol Sci"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00281-013-0361-0","volume":"35","author":"Mitroulis I.","year":"2013","unstructured":"Mitroulis I.; Kambas K.; Ritis K.; Neutrophils, IL-1\u03b2, and gout: Is there a link? Semin Immunopathol  2013,35(4),501-12","journal-title":"Semin Immunopathol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1111\/febs.16036","volume":"289","author":"Liu M.L.","year":"2022","unstructured":"Liu M.L.; Lyu X.; Werth V.P.; Recent progress in the mechanistic understanding of NET formation in neutrophils. FEBS J  2022,289(14),3954-3966","journal-title":"FEBS J"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1089\/jmf.2016.3705","volume":"19","author":"Daily JW.","year":"2016","unstructured":"Daily JW.; Yang M.; Park S.; Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: A systematic review and meta-analysis of randomized clinical trials. J Med food  2016,19(8),717-29","journal-title":"J Med food"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ptr.4639","volume":"26","author":"Chandran B.","year":"2012","unstructured":"Chandran B.; Goel A.; A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res  2012,26(11),1719-1725","journal-title":"Phytother Res"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00776-014-0633-0","volume":"19","author":"Nakagawa Y.","year":"2014","unstructured":"Nakagawa Y.; Mukai S.; Yamada S.; Matsuoka M.; Tarumi E.; Hashimoto T.; Tamura C.; Imaizumi A.; Nishihira J.; Nakamura T.; Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: A randomized, double-blind, placebo-controlled prospective study. J Orthop Sci  2014,19(6),933-939","journal-title":"J Orthop Sci"},{"key":"ref=135","author":"Dewangan A.K.","year":"2015","unstructured":"Dewangan A.K.; Varkey S.; Mazumder S.; Synthesis of curcumin loaded CMCAB nanoparticles for treatment of rheumatoid arthritis. International Conference on Chemical, Environmental and Biological Sciences (CEBS)  2015","journal-title":"International Conference on Chemical, Environmental and Biological Sciences (CEBS)"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejps.2015.07.012","volume":"78","author":"Coradini K.","year":"2015","unstructured":"Coradini K.; Friedrich R.B.; Fonseca F.N.; Vencato M.S.; Andrade D.F.; Oliveira C.M.; Battistel A.P.; Guterres S.S.; da Rocha M.I.U.M.; Pohlmann A.R.; Beck R.C.R.; A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies. Eur J Pharm Sci  2015,78,163-170","journal-title":"Eur J Pharm Sci"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ejp.620","volume":"19","author":"Arora R.","year":"2015","unstructured":"Arora R.; Kuhad A.; Kaur I.P.; Chopra K.; Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats. Eur J Pain  2015,19(7),940-952","journal-title":"Eur J Pain"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1016\/j.biomaterials.2013.05.055","volume":"34","author":"Xiang B.","year":"2013","unstructured":"Xiang B.; Dong D-W.; Shi N-Q.; Gao W.; Yang Z-Z.; Cui Y.; Cao D-Y.; Qi X-R.; PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer. Biomaterials  2013,34(28),6979-91","journal-title":"Biomaterials"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1002\/ptr.7190","volume":"35","author":"Khezri K.","year":"2021","unstructured":"Khezri K.; Saeedi M.; Mohammadamini H.; Zakaryaei A.S.; A comprehensive review of the therapeutic potential of curcumin nanoformulations. Phytother Res  2021,35(10),5527-5563","journal-title":"Phytother Res"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.3390\/pharmaceutics14102239","volume":"14","author":"Sun H.","year":"2022","unstructured":"Sun H.; Zhan M.; Mignani S.; Shcharbin D.; Majoral J-P.; Rodrigues J.; Shi X.; Shen M.; Modulation of macrophages using nanoformulations with curcumin to treat inflammatory diseases: A concise review. Pharmaceutics  2022,14(10),2239","journal-title":"Pharmaceutics"},{"key":"ref=141","first-page":"1","author":"Liu C.","year":"2023","unstructured":"Liu C.; Rokavec M.; Huang Z.; Hermeking H.; Curcumin activates a ROS\/KEAP1\/NRF2\/miR-34a\/b\/c cascade to suppress colorectal cancer metastasis. Cell Death Differ  2023,1-15","journal-title":"Cell Death Differ"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/ptr.7656","volume":"37","author":"Huang J.","year":"2023","unstructured":"Huang J.; Wu T.; Zhong Y.; Huang J.; Kang Z.; Zhou B.; Zhao H.; Liu D.; Effect of curcumin on regulatory B cells in chronic colitis mice involving  \/  signaling pathway. Phytother Res  2023,37(2),731-742","journal-title":"Phytother Res"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/cells12040612","volume":"12","author":"Miyazaki K.","year":"2023","unstructured":"Miyazaki K.; Morine Y.; Xu C.; Nakasu C.; Wada Y.; Teraoku H.; Curcumin-mediated resistance to lenvatinib via EGFR signaling pathway in hepatocellular carcinoma. Cells  2023,12(4),612","journal-title":"Cells"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.burns.2022.06.016","volume":"49","author":"Zhang H.","year":"2023","unstructured":"Zhang H.; Li H.; Wang H.; Lei S.; Yan LJB.; Overexpression of TRPM7 promotes the therapeutic effect of curcumin in wound healing through the STAT3\/SMAD3 signaling pathway in human fibroblasts. Burns  2023,49(4),889-900","journal-title":"Burns"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/molecules28020742","volume":"28","author":"Benameur T.","year":"2023","unstructured":"Benameur T.; Frota Gaban S.V.; Giacomucci G.; Filannino F.M.; Trotta T.; Polito R.; Messina G.; Porro C.; Panaro M.A.; The effects of curcumin on inflammasome: Latest update. Molecules  2023,28(2),742","journal-title":"Molecules"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"104921","DOI":"10.1016\/j.phrs.2020.104921.","volume":"159","author":"Hasanzadeh S.","year":"2020","unstructured":"Hasanzadeh S.; Read M.I.; Bland A.R.; Majeed M.; Jamialahmadi T.; Curcumin: An inflammasome silencer. Pharmacol Res  2020,159,104921","journal-title":"Pharmacol Res"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230721154653","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/219008\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230721154653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T07:14:03Z","timestamp":1720163643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/219008\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":146,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230721154653","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-02-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}